ArticleAmerican journal of translational research2025
Serological markers, pulmonary function, and prognosis in pediatric asthma: predictive model development and validation.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Immune and inflammatory mechanisms in asthma: insights into epigenetic modifications.Frontiers in immunology · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric asthma is a chronic and heterogeneous respiratory disease that poses considerable challenges in predicting exacerbations and long-term outcomes. This study aimed to enhance prognostic prediction for pediatric asthma by integrating serological markers with pulmonary function parameters.
methodsA retrospective analysis was conducted involving 318 pediatric asthma patients from one hospital, with external validation performed on an additional cohort of 283 patients from another institution. Serological markers, including white blood cell (WBC) count, eosinophil percentage, interleukins, 14-3-3β protein, and total immunoglobulin E (IgE), were measured alongside pulmonary function indicators such as forced expiratory volume in one second (FEV1) and the FEV1/forced vital capacity (FVC) ratio. Statistical analyses included correlation testing, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis to develop and validate the prognostic model.
resultsElevated WBC count, eosinophil percentage, 14-3-3β protein, and total IgE levels were significantly associated with poorer prognosis. Among interleukin profiles, increased interleukin-4 (IL-4) and interleukin-7 (IL-7) levels, along with reduced interleukin-10 (IL-10), were linked to unfavorable outcomes. In contrast, higher FEV1 and FVC values correlated with better outcomes. The integrated predictive model demonstrated strong predictive performance, with an area under the curve (AUC) of 0.818 in the modeling cohort and 0.874 in the validation cohort.
conclusionThe integration of serological biomarkers and pulmonary function indices provides a robust framework for predicting prognosis in pediatric asthma, supporting the development of individualized management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.